Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04482439 · ClinicalTrials.gov registry record · NA
Evaluation of Vision After Vivity IOL Implantation With a Target of Slight Myopia in the Non-dominant Eye
A NA study, sponsored by Newsom Eye & Laser Center.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT04482439: Completed NA study, sponsored by Newsom Eye & Laser Center.
NCT04482439 is a NA study that has completed, run by Newsom Eye & Laser Center. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04482439, a NA study, has completed, sponsored by Newsom Eye & Laser Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The objective is to assess binocular distance-corrected near (40 cm) visual acuity of patients after uneventful cataract surgery with bilateral implantation of the AcrySof® Vivity Intraocular lens (IOL) when the non-dominant eye is targeted for slight myopia.
Primary Outcome
binocular distance-corrected near (40 cm) visual acuity at 3 months postoperative.
Interventions
- DEVICE Vivity Extended Depth of Focus intraocular lens (IOL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-07-17 |
| Est. Completion | 2021-06-10 |
| Phase | NA |
What the finished NCT04482439 record still lists
NCT04482439 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Vivity Extended Depth of Focus intraocular lens (IOL) is the first listed.
NCT04482439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04482439 about?
NCT04482439 is a clinical study titled "Evaluation of Vision After Vivity IOL Implantation With a Target of Slight Myopia in the Non-dominant Eye". The objective is to assess binocular distance-corrected near (40 cm) visual acuity of patients after uneventful cataract surgery with bilateral implantation of the AcrySof® Vivity Intraocular lens (IOL) when the non-dominant eye is targeted for slight myopia.
What is the current status of trial NCT04482439?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2020-07-17. Estimated completion is 2021-06-10.
What interventions are being tested in trial NCT04482439?
The interventions under investigation include: Vivity Extended Depth of Focus intraocular lens (IOL) (DEVICE).
Who is sponsoring clinical trial NCT04482439?
This trial is sponsored by Newsom Eye & Laser Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04482439's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI